Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
---|
05/03/2007 | US20070099921 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/03/2007 | US20070099914 Piperidine Derivatives |
05/03/2007 | US20070099904 Pharmaceutical composition for the treatment of cns and other disorders |
05/03/2007 | US20070099899 Heterocyclic dihydropyrimidine compounds |
05/03/2007 | US20070099892 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
05/03/2007 | US20070099870 Lipid analogs for combating tumors |
05/03/2007 | US20070099832 Combination Therapy with p38 MAP Kinase Inhibitors and their Pharmaceutical Compositions |
05/03/2007 | US20070099297 Primitive and proximal hepatic stem cells |
05/03/2007 | US20070098705 Probiotic composition comprising at least two lactic acid bacterial strains which are able to clonise the gatrointestonal tracts in combination with having intestinal survival property, intestinal binding property, an infection protection property and fiber fermenting property |
05/03/2007 | US20070098688 Polymer conjugates of interferon beta-1a and uses |
05/03/2007 | US20070098680 Agent for treating diabetes mellitus |
05/03/2007 | US20070098634 method of inhibiting the growth; inhibiting neoplastic cell growth; cancer |
05/03/2007 | CA2627640A1 Therapeutic drug for suppressing functions of nkt cells containing glycolipid derivative as active ingredient |
05/03/2007 | CA2627139A1 Novel benzoxathiin derivative |
05/02/2007 | EP1780285A1 Improved virus like particles (VLP) based on the small envelope protein of hepatitis B virus (HBsAg-S) |
05/02/2007 | EP1780207A2 Crystalline esomeprazole strontium hydrate, method for preparing the same and pharmaceutical composition containing the same |
05/02/2007 | EP1780196A2 Pyridine derivatives for use as vanilloid receptor ligands |
05/02/2007 | EP1779863A1 Use of TGF-Beta and growth factors in the treatment and prevention of diseases of the intestinal mucosa |
05/02/2007 | EP1779854A1 Glycyrrhizin-containing suppository compositions for rectal infusion |
05/02/2007 | EP1779848A1 V-ATPase inhibitors for the treatment of inflammatory and autoimmune diseases |
05/02/2007 | EP1778292A2 Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract |
05/02/2007 | EP1778279A1 Pharmaceutical composition containing botulinum neurotoxin a2 |
05/02/2007 | EP1778272A1 Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (hcv) |
05/02/2007 | EP1778240A2 Dihydropteridinones for the treatment of cancer diseases |
05/02/2007 | EP1778225A2 Pyrrolo(oxo)isoquinolines as 5ht ligands |
05/02/2007 | EP1778209A1 Methods and compositions for oral delivery of fts |
05/02/2007 | EP1549637B1 1- (indol-3-yl)carbonyl piperazine derivatives |
05/02/2007 | EP1499589B1 Derivatives of n-phenyl(piperidin-2-yl)methyl benzamide, the preparation method thereof and application of same in therapeutics |
05/02/2007 | EP1408952B1 Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
05/02/2007 | EP1280826B1 Polypeptides for inhibiting april-mediated b- and t-cell proliferation. |
05/02/2007 | EP1261372B1 Method of treating cancer with anti-neurotrophin agents |
05/02/2007 | EP1228052B1 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants |
05/02/2007 | EP1226155B1 18-nor-steroids as selectively active estrogens |
05/02/2007 | EP1220830B1 Use of elastase for opening obstructed arteries and veins |
05/02/2007 | EP1077069B1 Preventives/remedies for hepatic cirrhosis |
05/02/2007 | EP1032405A4 Antimutagenic compositions for treatment and prevention of photodamage to skin |
05/02/2007 | CN2894699Y Film-coated tablet of norcantharidin |
05/02/2007 | CN1957084A Bone marrow-relevant cell participating the maintenance and/or repair of tissue |
05/02/2007 | CN1956979A Thiazole derivative |
05/02/2007 | CN1956971A Novel fused heterocycles and application thereof |
05/02/2007 | CN1956969A 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and 5-serotonin reuptake inhibitors |
05/02/2007 | CN1956728A Enzymes for pharmaceutical use |
05/02/2007 | CN1956719A Specific ppar excitant for treating negative energy equilibrium |
05/02/2007 | CN1956709A Dosage form containing the active ingredient cholylsarcosine |
05/02/2007 | CN1955280A Potency regeneration cell and culturing method thereof |
05/02/2007 | CN1955180A 1,2,3,4,7,8-hexahydro-6H-[1,4]diazepino[6,7,1-IJ] quinoline derivatives as antipsychotic and antiobesity agents |
05/02/2007 | CN1955179A [1,4]diazepino[6,7,1-IJ]quinoline derivatives as antipsychotic and antiobesity agents |
05/02/2007 | CN1955177A LAM nucleoside derivate, its preparation method and application |
05/02/2007 | CN1954882A Use of long active human recombination solubility tumor necrosin alpha receptor in preparation of medicine for treating hepatic failure |
05/02/2007 | CN1954881A Chinese medicinal composite for treating intestinal irritable syndrome and its preparation method |
05/02/2007 | CN1954879A Granule of zhamusa-four-does and its preparation method |
05/02/2007 | CN1954874A Curcuma zedoary oil fat injection and preparation process |
05/02/2007 | CN1954866A Medicine for treating odontopathy and its preparation method |
05/02/2007 | CN1954865A Oral liquid for kidney-tonifying and strengthening yang and its preparation method |
05/02/2007 | CN1954864A Life-saving pill for acute abdomen |
05/02/2007 | CN1954863A Traditional Chinese medicinal composite for treating tunica mucosa oris ulcer and its preparation method |
05/02/2007 | CN1954859A Mongolia medicine composite for treating chronic cholecystitis, cholecystalgia and its method |
05/02/2007 | CN1954844A Traditional Chinese medicine for treating macous membrane of mouth disease |
05/02/2007 | CN1954843A Traditional Chinese medicine plaster for treating tunica mucosa oris ulcer and its preparation method |
05/02/2007 | CN1954837A Compound herba sophorae alopecuroide active region group and its colon location preparation |
05/02/2007 | CN1954835A Sea-buckthorn plant preparation and its preparation method |
05/02/2007 | CN1954833A Medicine for treating toothache |
05/02/2007 | CN1954827A Liandan anti-inflammatory dripping pills and its preparation method |
05/02/2007 | CN1954806A Teprenone orally disintegrating tablet prescription and its preparation method |
05/02/2007 | CN1954698A Health-care food for regulating gastrointestinal tract function and its preparation process |
05/02/2007 | CN1313589C Medicinal liquor and its preparing method |
05/02/2007 | CN1313459C Total flavone glycoside extract of Radix scutellariae, Rodix scutellariae monomer flavone glycoside, its preparation and use |
05/02/2007 | CN1313450C Tachykinin receptor antagonists |
05/02/2007 | CN1313448C Metalloproteinase inhibitors |
05/02/2007 | CN1313152C Vaccines |
05/02/2007 | CN1313148C HSA-free formulations of interferon-Beta |
05/02/2007 | CN1313135C Medicine for treating ulcer |
05/02/2007 | CN1313130C Medicine composition for treating stomachache, its preparation method and uses |
05/02/2007 | CN1313113C 'Wudan Xinggan' granular for treating fatty liver, and its prepn. method |
05/02/2007 | CN1313102C Health caring capsule of soft-shelled turtle and its preparation method |
05/02/2007 | CN1313091C Vitamin C composition |
05/02/2007 | CN1313088C Napthoquinone derivatives as inhibitors of tau aggregation for the treatment of alzheimer's and related neurodegenerative disorders |
05/02/2007 | CN1313087C Preparation method for increasing dissolution of sofalcone |
05/02/2007 | CN1313085C Application of total hypone of radix cynanchi bungei and hypnone for preparing medicine for treating gastrointestinal tract diseases |
05/01/2007 | US7211694 Substituted 4-aminocyclohexanols |
05/01/2007 | US7211669 therapy for depression; anxiolytic agents; eating disorders; post-traumatic stress disorders; headaches; drug addition; antiinflammatory agents |
05/01/2007 | US7211601 Prevention labor contraction; urogenital disorders |
05/01/2007 | US7211600 Methods of modulating c-kit tyrosine protein kinase function with indolinone compounds |
05/01/2007 | US7211598 Oxime and/or hydrozone containing nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use |
05/01/2007 | US7211590 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers |
05/01/2007 | US7211586 Substituted tetrahydroisoquinolines |
05/01/2007 | US7211578 Nitrogenous tetrahydropyridyl-alkyl-heterocycles with TNF activity |
05/01/2007 | US7211575 Methods of treating cytokine mediated diseases |
05/01/2007 | US7211563 For use in diagnosis, study, prophylaxis, and therapy of diseases and disorders related to body-weight regulation, metabolic diseases such as obesity, as well as related disorders such as adipositas, eating disorders, cachexia |
05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
05/01/2007 | US7211404 Liver engrafting cells, assays, and uses thereof |
05/01/2007 | US7211276 Method for preventing ulceration or irritation of mucosa |
05/01/2007 | US7211261 Stable liquid formulations of botulinum toxin |
05/01/2007 | US7211258 Protein A compositions and methods of use |
05/01/2007 | US7211254 Nucleotide sequences coding interleukin-9 induced calcium activated chloride channel for use in identifying modulators for treatment and prevention of asthma, allergies and respiratory system disorders |
05/01/2007 | CA2366679C Stabilized oral pharmaceutical composition containing iodide and iodate and method |
05/01/2007 | CA2340545C Chelate compound-containing antibacterial agent for helicobacter pylori |
05/01/2007 | CA2320706C 20-hete antagonists and agonists |
05/01/2007 | CA2290893C Magnesium omeprazole |
05/01/2007 | CA2214343C Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |